rs606231198
Variant summary
Our verdict is Benign. Variant got -14 ACMG points: 2P and 16B. PM4BP6_Very_StrongBS1BS2
The NM_001032382.2(PQBP1):c.334_354delAGGGGCCATGACAAGTCGGAC(p.Arg112_Asp118del) variant causes a conservative inframe deletion change. The variant allele was found at a frequency of 0.000784 in 1,208,929 control chromosomes in the GnomAD database, including 3 homozygotes. There are 426 hemizygotes in GnomAD. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.00046 ( 1 hom., 17 hem., cov: 21)
Exomes 𝑓: 0.00082 ( 2 hom. 409 hem. )
Consequence
PQBP1
NM_001032382.2 conservative_inframe_deletion
NM_001032382.2 conservative_inframe_deletion
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 4.52
Genes affected
PQBP1 (HGNC:9330): (polyglutamine binding protein 1) This gene encodes a nuclear polyglutamine-binding protein that is involved with transcription activation. The encoded protein contains a WW domain. Mutations in this gene have been found in patients with Renpenning syndrome 1 and other syndromes with X-linked cognitive disability. Multiple alternatively spliced transcript variants that encode different protein isoforms have been described for this gene.[provided by RefSeq, Nov 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -14 ACMG points.
PM4
Nonframeshift variant in NON repetitive region in NM_001032382.2.
BP6
Variant X-48902256-AGCCATGACAAGTCGGACAGGG-A is Benign according to our data. Variant chrX-48902256-AGCCATGACAAGTCGGACAGGG-A is described in ClinVar as [Likely_benign]. Clinvar id is 10984.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population sas. gnomad4 allele frequency = 0.000461 (51/110709) while in subpopulation SAS AF= 0.00698 (18/2578). AF 95% confidence interval is 0.00451. There are 1 homozygotes in gnomad4. There are 17 alleles in male gnomad4 subpopulation. Median coverage is 21. This position pass quality control queck.
BS2
High Hemizygotes in GnomAd4 at 17 XL gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PQBP1 | NM_001032382.2 | c.334_354delAGGGGCCATGACAAGTCGGAC | p.Arg112_Asp118del | conservative_inframe_deletion | 5/7 | ENST00000447146.7 | NP_001027554.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PQBP1 | ENST00000447146.7 | c.334_354delAGGGGCCATGACAAGTCGGAC | p.Arg112_Asp118del | conservative_inframe_deletion | 5/7 | 1 | NM_001032382.2 | ENSP00000391759.2 |
Frequencies
GnomAD3 genomes AF: 0.000461 AC: 51AN: 110659Hom.: 1 Cov.: 21 AF XY: 0.000516 AC XY: 17AN XY: 32915
GnomAD3 genomes
AF:
AC:
51
AN:
110659
Hom.:
Cov.:
21
AF XY:
AC XY:
17
AN XY:
32915
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000944 AC: 173AN: 183289Hom.: 0 AF XY: 0.00146 AC XY: 99AN XY: 67777
GnomAD3 exomes
AF:
AC:
173
AN:
183289
Hom.:
AF XY:
AC XY:
99
AN XY:
67777
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000817 AC: 897AN: 1098220Hom.: 2 AF XY: 0.00112 AC XY: 409AN XY: 363584
GnomAD4 exome
AF:
AC:
897
AN:
1098220
Hom.:
AF XY:
AC XY:
409
AN XY:
363584
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000461 AC: 51AN: 110709Hom.: 1 Cov.: 21 AF XY: 0.000516 AC XY: 17AN XY: 32975
GnomAD4 genome
AF:
AC:
51
AN:
110709
Hom.:
Cov.:
21
AF XY:
AC XY:
17
AN XY:
32975
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign/Likely benign
Submissions summary: Pathogenic:1Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Renpenning syndrome Pathogenic:1Benign:1
Pathogenic, no assertion criteria provided | literature only | OMIM | Apr 01, 2006 | - - |
Likely benign, criteria provided, single submitter | clinical testing | Mendelics | May 28, 2019 | - - |
not specified Benign:2
Benign, criteria provided, single submitter | clinical testing | Athena Diagnostics | Mar 22, 2017 | - - |
Benign, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Jan 10, 2014 | - - |
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 25, 2023 | - - |
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Aug 01, 2023 | PQBP1: BS2 - |
PQBP1-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Jan 08, 2020 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at